SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,555 | +32.2% | 3,212 | +44.2% | 0.04% | +7.9% |
| Q2 2023 | $66,974 | -34.0% | 2,228 | -20.4% | 0.04% | -32.1% |
| Q1 2023 | $101,444 | -10.7% | 2,800 | -12.1% | 0.06% | -12.5% |
| Q4 2022 | $113,645 | +24.9% | 3,186 | +19.3% | 0.06% | +14.3% |
| Q3 2022 | $91,000 | -99.9% | 2,671 | +0.3% | 0.06% | +19.1% |
| Q2 2022 | $77,014,000 | +219940.0% | 2,663 | +143.0% | 0.05% | +62.1% |
| Q1 2022 | $35,000 | -16.7% | 1,096 | -24.1% | 0.03% | +7.4% |
| Q4 2021 | $42,000 | +61.5% | 1,444 | +46.6% | 0.03% | +92.9% |
| Q3 2021 | $26,000 | -33.3% | 985 | -16.7% | 0.01% | -54.8% |
| Q2 2021 | $39,000 | – | 1,183 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |